Clinical trial
An Evaluation of Semen Characteristics After 40 Weeks Daily Dosing With 20 mg Tadalafil
NCT00382135 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Evaluation of Semen Characteristics After 40 Weeks Daily Dosing With 20 mg Tadalafil
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2003
- Completion date
- December 31, 2005
- Enrollment
- 282 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.